These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25315411)

  • 1. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example.
    Xie F; Ji S; Cheng Z
    Eur J Pharm Sci; 2015 Jan; 66():163-72. PubMed ID: 25315411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match?
    Duan JZ; Riviere K; Marroum P
    Pharm Res; 2011 May; 28(5):1144-56. PubMed ID: 21287250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles.
    Kwon M; Yeom D; Kim NA; Choi du H; Park J; Wang H; Yoo SD; Jeong SH
    Arch Pharm Res; 2015 Jan; 38(1):73-80. PubMed ID: 24627339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo equivalence of two oral atenolol tablet formulations.
    Cuadrado A; Rodríguez Gascón A; Hernández RM; Castilla AM; de la Maza A; López de Ocáriz A; Calvo B; Pedraz JL
    Arzneimittelforschung; 2002; 52(5):371-8. PubMed ID: 12087922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.
    de Freitas Silva M; Schramm SG; Kano EK; Koono EE; Manfio JL; Porta V; dos Reis Serra CH
    Arzneimittelforschung; 2012 Oct; 62(10):490-5. PubMed ID: 22918856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers.
    Quetglas EG; Campanero MA; Sádaba B; Escolar M; Azanza JR
    Arzneimittelforschung; 2008; 58(6):283-7. PubMed ID: 18677970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioequivalence study of two marketed formulation of betamethasone injectable suspensions.
    Zakeri-Milani P; Ghanbarzadeh S; Basmenji S; Valizadeh H
    Drug Res (Stuttg); 2013 Oct; 63(10):545-9. PubMed ID: 23780505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simulation of bioequivalence study on the base of dissolution curves].
    Grezál G; Vereczkey L
    Acta Pharm Hung; 2012; 82(2):55-9. PubMed ID: 22870777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Dissolution Similarity Assessment Methods for Products with Large Variations: f
    Yoshida H; Shibata H; Izutsu KI; Goda Y
    Biol Pharm Bull; 2017; 40(5):722-725. PubMed ID: 28458360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advantages of combination therapy on hypertension: development of immediate release perindopril-indapamide tablet and assessment of bioequivalence studies.
    Ölçer A; Ölçer M; İnce I; Karasulu E
    Pharm Dev Technol; 2016 Mar; 21(2):239-49. PubMed ID: 26794937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test.
    Shin MC; Kim JK; Kim CK
    Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory assessment of drug dissolution profiles comparability via maximum deviation.
    Moellenhoff K; Dette H; Kotzagiorgis E; Volgushev S; Collignon O
    Stat Med; 2018 Sep; 37(20):2968-2981. PubMed ID: 29862526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
    Wong H; Ozalp Y; Lainesse A; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of two commercial amoxicillin suspension formulations in healthy human volunteers.
    Franco GC; Baglie S; Ruenis AP; Franco LM; Cogo K; Oshima-Franco Y; Silva P; Groppo FC; Rosalen PL
    Int J Clin Pharmacol Ther; 2014 May; 52(5):425-30. PubMed ID: 24755132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle Size Distribution Equivalency as Novel Predictors for Bioequivalence.
    Ngeacharernkul P; Stamatis SD; Kirsch LE
    AAPS PharmSciTech; 2018 Oct; 19(7):2787-2800. PubMed ID: 30117041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the bioequivalence of two faropenem formulations in healthy Indian subjects.
    Bhaumik U; Ghosh A; Chakrabarty US; Mandal U; Bose A; Das A; Ray KK; Pal TK
    Arzneimittelforschung; 2008; 58(12):681-5. PubMed ID: 19202741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.